Viewing Study NCT01600092


Ignite Creation Date: 2025-12-24 @ 3:56 PM
Ignite Modification Date: 2025-12-27 @ 12:17 PM
Study NCT ID: NCT01600092
Status: COMPLETED
Last Update Posted: 2018-11-14
First Post: 2012-05-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of the Immunogenicity, Tolerability, and Safety of a New Formulation of RotaTeqâ„¢ in Infants (V260-035)
Sponsor: Merck Sharp & Dohme LLC
Organization: